mollisurgical.com/jo-taylor-2/
Nov 7, 2024, 07:14
Jo Taylor: We Need Drug Developments to Overcome Access Inequality in the UK
Jo Taylor, Founder of After Breast Cancer Diagnosis, posted the following on X:
“We need drug developments to get through the broken National Institute for Health and Care Excellence severity modifier system & available on NHS England because now we have an inequality in the UK where Scotland can access Enhertu for HER2low but England, Wales & Northern Ireland can’t…
Its a crazy situ that patients are in.
Shame on those who stopped this from being approved… I can only see that this will cause big problems for pharma in the future & we METUPUK worry for what will happen…
Awareness & mammograms wont help us – whats the point of a new drug if its not there to help patients survive? Where are the outcomes?”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 13, 2024, 16:51
Nov 13, 2024, 16:49
Nov 13, 2024, 16:45
Nov 13, 2024, 16:25
Nov 13, 2024, 16:23
Nov 13, 2024, 16:08
Nov 13, 2024, 16:02
Nov 13, 2024, 15:56